Skip to Content

GS EUG 225 (Propafenone hydrochloride extended release 225 mg)

Pill with imprint GS EUG 225 is White, Capsule-shape and has been identified as Propafenone hydrochloride extended release 225 mg. It is supplied by Prasco Laboratories.

Propafenone is used in the treatment of atrial fibrillation; wolff-parkinson-white syndrome; atrial flutter; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for GS EUG 225

Propafenone hydrochloride extended release

GS EUG 225
225 mg
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Prasco Laboratories
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.